GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Human Xtensions Ltd (XTAE:HUMX) » Definitions » EV-to-EBITDA

Human Xtensions (XTAE:HUMX) EV-to-EBITDA : -0.31 (As of Apr. 29, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Human Xtensions EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Human Xtensions's enterprise value is ₪4.72 Mil. Human Xtensions's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was ₪-15.45 Mil. Therefore, Human Xtensions's EV-to-EBITDA for today is -0.31.

The historical rank and industry rank for Human Xtensions's EV-to-EBITDA or its related term are showing as below:

XTAE:HUMX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -168.77   Med: 0.08   Max: 1.11
Current: -0.31

During the past 7 years, the highest EV-to-EBITDA of Human Xtensions was 1.11. The lowest was -168.77. And the median was 0.08.

XTAE:HUMX's EV-to-EBITDA is ranked worse than
100% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 14.93 vs XTAE:HUMX: -0.31

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-04-29), Human Xtensions's stock price is ₪0.327. Human Xtensions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₪-0.610. Therefore, Human Xtensions's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Human Xtensions EV-to-EBITDA Historical Data

The historical data trend for Human Xtensions's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Human Xtensions EV-to-EBITDA Chart

Human Xtensions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial -20.87 -0.58 0.92 -0.33 -0.17

Human Xtensions Quarterly Data
Dec18 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.54 -0.05 -0.33 0.12 -0.17

Competitive Comparison of Human Xtensions's EV-to-EBITDA

For the Medical Devices subindustry, Human Xtensions's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Xtensions's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Human Xtensions's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Human Xtensions's EV-to-EBITDA falls into.


;
;

Human Xtensions EV-to-EBITDA Calculation

Human Xtensions's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4.724/-15.45
=-0.31

Human Xtensions's current Enterprise Value is ₪4.72 Mil.
Human Xtensions's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-15.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Human Xtensions  (XTAE:HUMX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Human Xtensions's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.327/-0.610
=At Loss

Human Xtensions's share price for today is ₪0.327.
Human Xtensions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-0.610.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Human Xtensions EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Human Xtensions's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Human Xtensions Business Description

Traded in Other Exchanges
N/A
Address
Meir Ariel 4, Tel Aviv, ISR
Human Xtensions Ltd is engaged in the business of developing handheld digital solutions for minimally invasive surgery. It develops unmediated surgical systems that combine the capacity of robotics with the benefits of handheld tools and ergonomic bed mounts. The company's product, HandX, is designed as a light-weight, hand-held device that translates the surgeon's natural hand motions into complex movements inside the patient.

Human Xtensions Headlines

No Headlines